Keyword: Tandem Diabetes Care
The FDA approved its first automatic insulin dosing system designed to deliver correction boluses as well as adjust background insulin levels.
A clinical trial of an artificial pancreas system showed that it was able to outperform current treatments for people with Type 1 diabetes.
Abbott teamed up with Omada Health to offer its FreeStyle Libre CGM system through the latter’s digital care program for type 2 diabetes.
The FDA has approved a new type of insulin pump that can be used with different components from other diabetes therapy systems.
Tandem Diabetes Care launched a new predictive feature for automatically pausing insulin delivery as a free update for its CGM-enabled insulin pumps.
CMS covers traditional insulin pumps, but not tubeless patch pumps, causing concern around innovation as well as patient access.
Here is Wednesday's dose of medtech news of note.
The FDA approved the integration of Tandem's touchscreen insulin pump and Dexcom's G5 CGM.
Here's this week's medtech news of note.
Tandem started a pivotal trial of a system that automatically stops insulin delivery when a patient’s blood glucose levels are predicted to fall.